California Public Employees Retirement System
NBIX icon

California Public Employees Retirement System’s Neurocrine Biosciences NBIX Stock Holding History

California Public Employees Retirement System’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.3M Buy
222,441
+25,620
+13% +$3.4M 0.02% 497
2025
Q4 		$27.9M Buy
196,821
+2,664
+1% +$386K 0.02% 534
2025
Q3 		$27.3M Buy
194,157
+20,788
+12% +$2.82M 0.02% 542
2025
Q2 		$21.8M Buy
173,369
+6,504
+4% +$746K 0.01% 590
2025
Q1 		$18.5M Sell
166,865
-286,226
-63% -$36.3M 0.01% 621
2024
Q4 		$61.8M Sell
453,091
-9,056
-2% -$1.12M 0.04% 339
2024
Q3 		$53.2M Sell
462,147
-22,873
-5% -$3.14M 0.04% 386
2024
Q2 		$66.8M Sell
485,020
-95,597
-16% -$13.1M 0.05% 320
2024
Q1 		$80.1M Sell
580,617
-6,333
-1% -$865K 0.06% 301
2023
Q4 		$77.3M Sell
586,950
-5,035
-0.9% -$580K 0.06% 295
2023
Q3 		$66.6M Buy
591,985
+4,755
+0.8% +$501K 0.06% 309
2023
Q2 		$55.4M Sell
587,230
-16,496
-3% -$1.61M 0.05% 349
2023
Q1 		$61.1M Sell
603,726
-27,808
-4% -$2.89M 0.05% 323
2022
Q4 		$75.4M Sell
631,534
-18,250
-3% -$2.14M 0.06% 302
2022
Q3 		$69M Buy
649,784
+4,280
+0.7% +$434K 0.06% 299
2022
Q2 		$62.9M Sell
645,504
-10,071
-2% -$929K 0.06% 295
2022
Q1 		$61.5M Buy
655,575
+26,693
+4% +$2.26M 0.05% 340
2021
Q4 		$53.6M Buy
628,882
+418,990
+200% +$38.5M 0.04% 404
2021
Q3 		$20.1M Sell
209,892
-1,134
-0.5% -$107K 0.02% 661
2021
Q2 		$20.5M Sell
211,026
-11,926
-5% -$1.14M 0.02% 679
2021
Q1 		$21.7M Sell
222,952
-3,136
-1% -$329K 0.02% 653
2020
Q4 		$21.7M Buy
226,088
+14,882
+7% +$1.44M 0.02% 627
2020
Q3 		$20.3M Buy
211,206
+5,200
+3% +$602K 0.02% 571
2020
Q2 		$25.1M Buy
206,006
+1,052
+0.5% +$116K 0.02% 484
2020
Q1 		$17.7M Buy
204,954
+13,529
+7% +$1.32M 0.02% 509
2019
Q4 		$20.6M Buy
191,425
+40,025
+26% +$4.19M 0.02% 601
2019
Q3 		$13.6M Buy
151,400
+30,900
+26% +$2.89M 0.01% 722
2019
Q2 		$10.2M Sell
120,500
-3,600
-3% -$296K 0.01% 747
2019
Q1 		$10.9M Sell
124,100
-42,576
-26% -$3.56M 0.01% 755
2018
Q4 		$11.9M Sell
166,676
-12,400
-7% -$1.19M 0.02% 681
2018
Q3 		$22M Buy
179,076
+14,350
+9% +$1.63M 0.03% 564
2018
Q2 		$16.2M Sell
164,726
-23,398
-12% -$2.09M 0.02% 663
2018
Q1 		$15.6M Sell
188,124
-4,011
-2% -$339K 0.02% 685
2017
Q4 		$14.9M Buy
192,135
+10,235
+6% +$698K 0.02% 712
2017
Q3 		$11.1M Buy
181,900
+2,600
+1% +$137K 0.02% 810
2017
Q2 		$8.25M Buy
179,300
+3,900
+2% +$189K 0.01% 951
2017
Q1 		$7.59M Sell
175,400
-7,600
-4% -$326K 0.01% 998
2016
Q4 		$7.08M Sell
183,000
-9,400
-5% -$426K 0.01% 1043
2016
Q3 		$9.74M Sell
192,400
-43,700
-19% -$2.18M 0.02% 851
2016
Q2 		$10.7M Sell
236,100
-6,200
-3% -$285K 0.02% 800
2016
Q1 		$9.58M Buy
242,300
+58,100
+32% +$2.31M 0.02% 845
2015
Q4 		$10.4M Buy
184,200
+25,600
+16% +$1.3M 0.02% 842
2015
Q3 		$6.31M Buy
158,600
+4,400
+3% +$213K 0.01% 1107
2015
Q2 		$7.37M Buy
154,200
+13,800
+10% +$585K 0.01% 1100
2015
Q1 		$4.71M Hold
140,400
– – 0.01% 1447
2014
Q4 		$4.71M Buy
140,400
+36,900
+36% +$699K 0.01% 1447
2014
Q3 		$1.62M Hold
103,500
– – ﹤0.01% 2194
2014
Q2 		$1.54M Hold
103,500
– – ﹤0.01% 2273
2014
Q1 		$1.46M Buy
103,500
+4,900
+5% +$83.8K ﹤0.01% 2286
2013
Q4 		$928K Sell
98,600
-155
-0.2% -$1.51K ﹤0.01% 2619
2013
Q3 		$1.12M Buy
98,755
+23,200
+31% +$319K ﹤0.01% 2320
2013
Q2 		$1.01M Buy
+75,555
New +$928K ﹤0.01% 2253

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System's NBIX Position: Q1 2026 in Review

California Public Employees Retirement System increased its Neurocrine Biosciences (NBIX) stake by 13% in Q1 2026, buying an estimated $3.4M and bringing the position to 222,441 shares worth $29.3M. The position accounts for 0.02% of the portfolio, ranked #497.

California Public Employees Retirement System first reported a position in NBIX in Q2 2013 and has held it in 52 quarters since. The position peaked at $80.1M in Q1 2024. 695 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • California Public Employees Retirement System held 222,441 shares of Neurocrine Biosciences worth $29.3M as of Q1 2026.
  • California Public Employees Retirement System bought 25,620 Neurocrine Biosciences shares in Q1 2026, an estimated $3.4M.
  • Neurocrine Biosciences made up 0.02% of California Public Employees Retirement System's portfolio in Q1 2026, its #497 holding.
  • California Public Employees Retirement System first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 52 quarters since.
  • California Public Employees Retirement System's Neurocrine Biosciences position peaked at $80.1M in Q1 2024.
  • 695 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on California Public Employees Retirement System's 13F filing for Q1 2026, filed 6 May 2026.